News from cormedix inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 05, 2015, 18:52 ET
CorMedix Logo

CorMedix, Inc. to Report First Quarter Financial Results on May 8, 2015

 CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment...

Apr 23, 2015, 08:00 ET
CorMedix Logo

CorMedix Presents Data from Neutrolin® Post Marketing Surveillance Study At Two Medical Conferences

 CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...

Apr 09, 2015, 08:00 ET
CorMedix Logo

CorMedix Institutes Program to Reduce Neutrolin® Cost of Goods; Reports on Strategic Review Process Managed by Evercore

 CorMedix Inc. (NYSE MKT: CRMD), a global biopharmaceutical company focused on developing and commercializing therapeutic products for the...

Mar 31, 2015, 18:00 ET
CorMedix Logo

CorMedix Receives Audit Opinion with Going Concern Explanation

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Mar 20, 2015, 08:00 ET
CorMedix Logo

CorMedix Announces Effectiveness of Registration Statements for Shares Underlying Publicly Traded Warrants

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Mar 09, 2015, 09:00 ET
CorMedix Logo

CorMedix Clarifies Extension of Expiration Date for Publicly Traded Warrants

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Mar 04, 2015, 08:00 ET
CorMedix Logo

CorMedix Inc. Provides Multiple Strategic Business Updates

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Jan 29, 2015, 09:00 ET
CorMedix Logo

FDA Grants QIDP Designation to Neutrolin®, CorMedix Inc.'s Lead Product Candidate in the U.S.

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Jan 15, 2015, 10:34 ET
CorMedix Logo

CorMedix Inc. Receives Fast Track Designation for Neutrolin®

 CorMedix Inc. (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing...

Dec 23, 2014, 08:30 ET
CorMedix Logo

CorMedix Inc. Finalizes First Middle East Neutrolin® Sales/Distribution Agreement in the Kingdom of Saudi Arabia

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Dec 04, 2014, 09:22 ET
CorMedix Logo

CorMedix Inc. Files Request with FDA for QIDP Designation for Neutrolin®

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Dec 03, 2014, 14:09 ET

Neutrolin Label Expansion Approved in Germany

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Nov 06, 2014, 16:08 ET
CorMedix Logo.

CorMedix, Inc. to Announce Third Quarter 2014 Results on November 13, 2014; Conference call hosted at 9 am on Friday, November 14, 2014

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing therapeutic products for...

Sep 25, 2014, 08:00 ET

CorMedix Announces FDA IND Filing for Neutrolin® in United States

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Sep 22, 2014, 08:00 ET

Neutrolin Label Expansion Approved for the European Union

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Sep 16, 2014, 08:00 ET

CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...

Aug 14, 2014, 16:45 ET

FDA Accepts CorMedix, Inc. Pivotal Phase 3 Study Protocol

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Jul 24, 2014, 12:30 ET

CorMedix, Inc. Granted Extension of NYSE-MKT Listing

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Jun 23, 2014, 16:15 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix, Inc. Finalizes Pivotal Phase 3 Study Protocol for FDA

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

May 23, 2014, 16:15 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Notified of NYSE MKT Listing Deficiency

 CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...